Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
InitVerse Unveils SaaS dApp Builder and Prepares for Mainnet Launch at Token2049
-
Mount Sinai Health System and Noom Partner to Help Patients Achieve Healthy Weight Loss Outcomes With an On-Demand Digital Health Platform
-
Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy
-
Form 8.3 - Keywords Studios plc - Octopus Investments
-
Del Taco Continues to Expand Presence Throughout Florida With 13th Location Opening Soon
-
GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment
-
MT Højgaard Holding A/S: Rasmus Untidt appointed CEO of MT Højgaard Holding
-
DEADLINE NEXT WEEK: Berger Montague Advises Arbor Realty Trust (NYSE: ABR) Investors to Contact the Firm Before September 30, 2024
-
OKX Lists POL on its Perpetual Futures Market
-
PTX Metals’ Green Canada Subsidiary Announces Acquisition of Thelon Basin Uranium Claims
-
Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents
-
Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders
-
PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month
-
KULR Secures Expanded U.S. Army Battery Contract to $2.4M, Paving Way for KULR ONE Guardian Battery Production in 2025
-
SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial
-
RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians
-
Qlik Joins the UN Global Compact, Strengthening 10-Year Partnership with the United Nations
-
Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split
-
Schellman Becomes First ISO 42001 ANAB Accredited Certification Body, Underscoring Commitment to Responsible AI
-
Byrna Technologies to Report Fiscal Third Quarter 2024 Financial Results on Wednesday, October 9, 2024 at 9:00 a.m. ET
-
Data Storage Corporation Secures Expanded Contract Servicing a Billion Dollar Insurance Company
-
UK’s Largest Greenhouse Complex, Thanet Earth, Adopts Intelligent Bio Solutions’ Fingerprint Drug Test to Enhance Workplace Safety
-
HeartCore’s Go IPO Client, SBC Medical Group, Begins Trading on the Nasdaq Stock Exchange
-
Coloplast A/S - Financial Calendar 2024-25
-
Spherix Global Insights Expands into Financial Services, Empowering Asset Managers and Hedge Funds with Critical Pharmaceutical Market Insights
-
Arq Publishes its First-Ever ESG Report
-
Windtree Announces Positive Topline Results from Its Phase 2b SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock
-
NEWTON GOLF Introduces New Gravity Putter Line, Building on Momentum from Recent Rebranding
-
FinWise Bancorp Announces Strategic Lending Program with PowerPay to Offer Transparent and Affordable Monthly Payments for Home Improvement and Elective Healthcare Purchases
-
Alliance Trust PLC - Net Asset Value
-
Fixing of coupon rate effective from 1 October 2024
-
Form 8.3 - ASCENTIAL PLC
-
VVC – Extension of Series AG Warrants
-
AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies
-
CENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology
-
3Daughters Announces NIH to Support Testing of Novel Frameless Magnetic Copper IUD (3D-001) for Contraception
-
Mineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of Hypertension
-
Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference
-
Asia Broadband Gold Production Continues Upward Trend For Third Quarter, As Ore Stockpile Processing Plant Advances Towards Completion
-
Haywood Street Community Development’s Nourish & Nest Brings Million Dollar Fundraising Goal Within Reach
-
Avadel Pharmaceuticals Announces Publication of Data Highlighting Efficacy of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension in Improving Narcolepsy Symptoms Regardless of Concomitant Use
-
HP Strengthens Workforce Experience Platform with Acquisition of Vyopta
-
Trace Announces All-Encompassing Rebrand, Unveils New Packaging & Products in its Mission to Remineralize the World
-
Elixirgen Therapeutics Receives Rare Pediatric Disease Designation for EXG-34217 in Dyskeratosis Congenita and Related Telomere Biology Disorders
-
Erasca to Present Preliminary SEACRAFT-1 Phase 1 Data for Naporafenib Plus Trametinib in RAS Q61X Mutant Solid Tumors as Oral Presentation at 36th EORTC-NCI-AACR Symposium
-
Virtuozzo Appoints Itay Nebenzahl as Chief Financial Officer
-
Calling All Paw-ty Animals: Trupanion to Connect Families & Shelter Pets for a Frightfully Howling Halloween
-
TTM Technologies, Inc. wins Cisco 2024 Supply Chain Security Champion Award
-
NV5 Announces 4-for-1 Stock Split; Enhances Accessibility of Stock Ownership for Employees and Investors
-
Sofwave to Participate in the Jefferies Virtual Private MedTech Summit
